Omthera
Omthera Pharmaceuticals develops therapies for patients with elevated triglyceride levels and increased risk of cardiovascular disease.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Omthera Information
Omthera was acquired by
AstraZeneca.
The acquisition happend on 2013-05-29.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Princeton
State: New Jersey
Zip:
Country: United States
Financial Info
Stage:
debt financing
Raised Last:
$18M
Raised Total:$60M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia. Led by a team of experts with exceptional experience in developing new therapies for lipid disorders, Omthera is dedicated to developing innovative therapies for the millions of patients who have elevated triglyceride levels and increased risk of cardiovascular disease.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2010 | Series A | 1 | $6.5M |
Sofinnova Partners Sofinnova Partners |
11/2009 | Venture Round | $2.2M | 2/2013 | Debt Financing | $17.6M | 3/2011 | Series B | 2 | $33.9M |
New Enterprise Associates Sofinnova Partners New Enterprise Associates Sofinnova Partners |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
